Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed
Search for other papers by Anna De Tullio in
Google Scholar
PubMed
Search for other papers by Olga Disoteo in
Google Scholar
PubMed
Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed
Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed
Search for other papers by Carlo Sabbà in
Google Scholar
PubMed
Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed
evaluate long-term effects ( 17 , 18 , 19 ). The incretin system and thyroid cancer A pivotal study found that the dipeptidyl peptidase type IV (DPP-IV), also known as cluster differentiation 26 (CD26), was expressed widely on the cell surface of
Search for other papers by Amalie R Lanng in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed
Search for other papers by Natasha C Bergmann in
Google Scholar
PubMed
Search for other papers by Sigrid Bergmann in
Google Scholar
PubMed
Search for other papers by Mads M Helsted in
Google Scholar
PubMed
Search for other papers by Matthew P Gillum in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
). Likewise, the effect of alcohol on the secretion of the gut-derived insulinotropic incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) remains unclear ( 6 , 11 , 12 ). Recently, alcohol was shown to
Search for other papers by Giovanni Fanni in
Google Scholar
PubMed
Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed
Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed
Search for other papers by Magnus Sundbom in
Google Scholar
PubMed
Search for other papers by Susanne Hetty in
Google Scholar
PubMed
Search for other papers by Maria J Pereira in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
metabolic shift is partly independent of weight loss, and the underlying mechanisms are not completely understood ( 3 , 4 , 5 , 6 ). Shortly after RYGB, a greater incretin response occurs post-prandially, which enhances insulin secretion, reduces food
Department of Endocrinology, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Lizhi Zhang in
Google Scholar
PubMed
Search for other papers by Jinwei He in
Google Scholar
PubMed
Search for other papers by Xiang Sun in
Google Scholar
PubMed
Search for other papers by Dongyue Pang in
Google Scholar
PubMed
Search for other papers by Jingjing Hu in
Google Scholar
PubMed
Search for other papers by Bo Feng in
Google Scholar
PubMed
Population in Beijing, China) for GIPR SNP rs10423928 using second-stage HapMap data ( ftp://ftp.ncbi.nlm.nih.gov/hapmap/ ). Both GLP-1 and GIP are incretins. Previously, we demonstrated a correlation between GLP-1 receptor gene ( GLP-1R ) polymorphisms and
Search for other papers by L Ahlkvist in
Google Scholar
PubMed
Search for other papers by K Brown in
Google Scholar
PubMed
Search for other papers by B Ahrén in
Google Scholar
PubMed
contribute to the upregulated β-cell function in insulin resistance, such as signals generated from nutrient metabolism, hormones, and cytokines (2) . We previously suggested that the incretin hormones may also contribute by demonstrating in model
Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed
Search for other papers by Othmar Moser in
Google Scholar
PubMed
Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed
Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed
Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed
Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed
Search for other papers by Harald Sourij in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Faculty of Medicine, University of Latvia, Riga, Latvia
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
perspectives in the combinatory use of incretin-based therapies in diabesity and physiological nature of hormonal crosstalk The primary objective of treating diabetes in particular novel pharmacological options leading to significant weight loss is to enhance
Search for other papers by Annieke C G van Baar in
Google Scholar
PubMed
Search for other papers by Andrei Prodan in
Google Scholar
PubMed
Search for other papers by Camilla D Wahlgren in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Steen S Poulsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Laboratory Medicine, University of Groningen, University Medical Center, Groningen, the Netherlands
Search for other papers by Albert K Groen in
Google Scholar
PubMed
Search for other papers by Jacques J Bergman in
Google Scholar
PubMed
Department of Internal Medicine, VUMC Free University, Amsterdam, the Netherlands
Wallenberg Laboratory, Sahlgrenska Hospital, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Horaizon BV, Delft, the Netherlands
Search for other papers by Evgeni Levin in
Google Scholar
PubMed
, metabolic syndrome (MetS) and type 2 diabetes ( 1 ). The gut incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), produced by enteroendocrine L cells and K cells, respectively, are intimately involved in
Search for other papers by Jothydev Kesavadev in
Google Scholar
PubMed
Search for other papers by Pradeep Babu Sadasivan Pillai in
Google Scholar
PubMed
Search for other papers by Arun Shankar in
Google Scholar
PubMed
Search for other papers by Gopika Krishnan in
Google Scholar
PubMed
Search for other papers by Sunitha Jothydev in
Google Scholar
PubMed
, many patients will eventually require to be shifted to another class of oral antidiabetic agents or insulin therapy ( 2 , 3 ). DPP-4 inhibitors are a class of oral antidiabetic drugs which enhance the function of endogenous incretin and help with
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Hanne Mumm in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Marianne Andersen in
Google Scholar
PubMed
). Incretin hormones are released after meal ingestion and account for up to 70% of postprandial insulin secretion ( 3 ). Glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide are the most important incretin hormones. GLP-1 secretion is impaired
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jeppe Skov in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Jens Peter Gøtze in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jørgen Frøkiær in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
Introduction Glucagon-like peptide-1 (GLP1) is a gut-derived incretin hormone with multiple actions in addition to control of glucose homeostasis (1) . Synthetic GLP1 receptor (GLP1R) agonists lower blood pressure in patients with type 2 diabetes